Q3 25 EPS
$7.83
BEAT +2.47%
Est. $7.64
Q3 25 Revenue
$69.75B
BEAT +4.50%
Est. $66.74B
vs S&P Since Q3 25
+8.3%
BEATING MARKET
CI +14.3% vs S&P +6.0%
Market Reaction
Did CI Beat Earnings? Q3 2025 Results
The Cigna Group delivered a strong third quarter for fiscal 2025, beating Wall Street expectations on both the top and bottom lines as its Evernorth Health Services segment continued to power growth across the enterprise. Adjusted earnings came in at… Read more The Cigna Group delivered a strong third quarter for fiscal 2025, beating Wall Street expectations on both the top and bottom lines as its Evernorth Health Services segment continued to power growth across the enterprise. Adjusted earnings came in at $7.83 per share, clearing the consensus estimate of $7.64 by 2.47%, while revenue climbed 9.5% year-over-year to $69.75 billion, topping the $66.74 billion estimate by 4.50%. The primary driver behind the outperformance was Evernorth, where pharmacy benefit services and specialty pharmacy volume growth pushed segment adjusted revenues up 15% to $60.39 billion, more than offsetting softer results in the Cigna Healthcare segment following the March 2025 divestiture of Medicare-related businesses to HCSC. Total pharmacy customers grew 4% to 122.5 million, underscoring the company's expanding scale in health services. Cigna also introduced a new rebate-free pharmacy benefit model aimed at improving cost transparency, signaling continued strategic investment in the segment. Management reaffirmed its full-year 2025 adjusted EPS outlook of at least $29.60 per share, providing investors with confidence heading into the final quarter.
Key Takeaways
- • Strong specialty pharmacy growth and increased biosimilar adoption in Evernorth
- • Growth of existing client relationships and new business in Pharmacy Benefit Services
- • Premium rate increases to cover expected increases in medical costs in Cigna Healthcare
- • Improved SG&A expense ratio from business mix shift
- • Lower share count from ongoing share repurchase program
CI YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
CI Revenue by Segment
With YoY comparisons, source: SEC Filings
“Our strong quarterly results reflect the breadth of our businesses and focused execution on our growth strategy, even in a dynamic environment.”
— David M. Cordani, Q3 2025 Earnings Press Release
CI Earnings Trends
CI vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CI EPS Trend
Earnings per share: estimate vs actual
CI Revenue Trend
Quarterly revenue: estimate vs actual
CI Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 | — | $7.79 | — | $68.49B | — |
| Q4 25 BEAT FY | $7.65 | $8.08 | +5.65% | $72.47B | +9.17% |
| FY Full Year | — | $29.84 | — | $274.90B | — |
| Q3 25 BEAT | $7.64 | $7.83 | +2.47% | $69.75B | +4.50% |
| Q2 25 BEAT | $7.15 | $7.20 | +0.65% | $67.18B | +7.30% |
| Q1 25 BEAT | $6.35 | $6.74 | +6.17% | $65.50B | +8.48% |